Quantification of clenbuterol in equine plasma, urine and tissue by liquid chromatography coupled on‐line with quadrupole time‐of‐flight mass spectrometry
- 25 July 2002
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 16 (17) , 1642-1651
- https://doi.org/10.1002/rcm.748
Abstract
Clenbuterol (CBL) is a potent β2‐adrenoceptor agonist used for the management of respiratory disorders in the horse. The detection and quantification of CBL can pose a problem due to its potency, the relatively low dose administered to the horse, its slow clearance and low plasma concentrations. Thus, a sensitive method for the quantification and confirmation of CBL in racehorses is required to study its distribution and elimination. A sensitive and fast method was developed for quantification and confirmation of the presence of CBL in equine plasma, urine and tissue samples. The method involved liquid‐liquid extraction (LLE), separation by liquid chromatography (LC) on a short cyano column, and pseudo multiple reaction monitoring (pseudo‐MRM) by electrospray ionization quadrupole time‐of‐flight tandem mass spectrometry (ESI‐QTOF‐MS/MS). At very low concentrations (picograms of CBL/mL), LLE produced better extraction efficiency and calibration curves than solid‐phase extraction (SPE). The operating parameters for electrospray QTOF and yield of the product ion in MRM were optimized to enhance sensitivity for the detection and quantification of CBL. The quantification range of the method was 0.013–10 ng of CBL/mL plasma, 0.05–20 ng/0.1 mL of urine, and 0.025–10 ng/g tissue. The detection limit of the method was 13 pg/mL of plasma, 50 pg/0.1 mL of urine, and 25 pg/g of tissue. The method was successfully applied to the analysis of CBL in plasma, urine and various tissue samples, and in pharmacokinetic (PK) studies of CBL in the horse. CBL was quantified for 96 h in plasma and 288 h in urine post‐administration of CLB (1.6 µg/kg, 2 × daily × 7 days). This method is useful for the detection and quantification of very low concentrations of CBL in urine, plasma and tissue samples. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 33 references indexed in Scilit:
- Intratracheal clenbuterol in the horse: its pharmacological efficacy and analytical detectionJournal of Veterinary Pharmacology and Therapeutics, 2000
- Supercritical fluid extraction (SFE) as a multi-residue extraction procedure for β-agonists in bovine liver tissueThe Analyst, 1999
- Dexamethasone and clenbuterol detection by enzyme immunoassay in Bovine Liver Tissue: A new multiresidue extraction procedureFood and Agricultural Immunology, 1998
- Matrix solid-phase dispersion as a multiresidue extraction technique for β-agonists in bovine liver tissueThe Analyst, 1994
- Combined immunoextraction approach coupled to a chemiluminescence enzyme immunoassay for the determination of trace levels of salbutamol and clenbuterol in tissue samplesThe Analyst, 1994
- Gas chromatographic/electron impact mass spectrometric selective confirmatory analysis of clenbuterol in human and bovine urineJournal of Mass Spectrometry, 1993
- Detection of clenbuterol residues in bovine liver, muscle, retina and urine using gas chromatography/mass spectrometryJournal of Mass Spectrometry, 1993
- Determination of clenbuterol residues in bovine liver, urine, and eye by enzyme immunoassayAnalytica Chimica Acta, 1993
- Determination of clenbuterol in bovine tissues and urine by enzyme immunoassayJournal of Agricultural and Food Chemistry, 1992
- Quantitative measurement of clenbuterol at the femtomole level in plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometryJournal of Mass Spectrometry, 1990